Injecting hope into UK equities: Short-term volatility worth the pain to reap long-term rewards

Vaccine roll-out raises hope for recovery

clock • 4 min read
Simon Young of AXA Investment Managers
Image:

Simon Young of AXA Investment Managers

For any UK investor reviewing 2020 and the falls seen in the FTSE All Share, and particularly dividend cuts, one’s attention naturally turns to the outlook for dividends from here and any lessons we may have learned.

One place to start is the recent past for clues about what the future may hold. Following the Global Financial Crisis (GFC) of 2008-09, dividends paid by FTSE All-Share constituents fell 21% from a peak...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on UK

Nick Train's trust has performed well so far this year
UK

Nick Train: 'several encouraging share prices' for companies in December

Outperformance in January

Nafeesa Zaman
clock 26 January 2022 • 2 min read
Industry Voice: Sustainable equities - maintain focus on long term secular growth

Industry Voice: Sustainable equities - maintain focus on long term secular growth

Hamish Chamberlayne, Head of Global Sustainable Equities, explains why investors should not be wrong-footed amid increased volatility in 2022.

Hamish Chamberlayne, Head of Global Sustainable Equities @ Janus Henderson Investors
clock 26 January 2022 • 7 min read
BB Biotech portfolio manager Dallas Webb

BB Biotech's Dallas Webb: 'The fundamentals of biotech have never been stronger'

Biotechnology Q&A

clock 24 January 2022 • 4 min read
Trustpilot